Skip to main content
Clinical Trials/ISRCTN14130025
ISRCTN14130025
Active, not recruiting
未知

Quantitative analysis of myocardial damage in patients with focal and diffuse fibrosis by applying novel parametric mapping techniques in cardiac magnetic resonance

Charité0 sites75 target enrollmentDecember 8, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Charité
Enrollment
75
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2020
End Date
May 31, 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Charité

Eligibility Criteria

Inclusion Criteria

  • 1\. Signed consent
  • 2\. Age at least 18 years (no upper limit)
  • 3\. For patients: previously detected pathology on MRI including: ischemic heart disease (acute, subacute and chronic stages), rheumatological disorders with cardiac manifestations, aortic stenosis, hypertrophic cardiomyopathy
  • 4\. For healthy volunteers: absence of cardiac, pulmonary, renal or systemic disorders

Exclusion Criteria

  • 1\. Any contraindication for MRI
  • 2\. Chronic renal failure (glomerular filtration rate \<30ml/min)
  • 3\. Previous participation in this study
  • 4\. Known allergy against MRI contrast agent
  • 5\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials